The conversion rate between asymptomatic infections and reported/unreported symptomatic infections is a very sensitive parameter for model variables that spread COVID-19. This is important information for follow-up use in screening, prediction, prognostics, contact tracing, and drug development for the COVID-19 pandemic. The model described here suggests that there may not be enough researchers to solve all of these problems thoroughly and effectively, and it requires careful selection of what we are doing and rapid sharing of results and models and optimizing modeling simulations with value to reduce the impact of COVID-19. Exploring simulation modeling will help decision makers make the most informed decisions. In order to fight against the “Delta” virus, the establishment of a line of defense through all-people testing (APT) is not only an effective method summarized from past experience but also one of the best means to effectively cut the chain of epidemic transmission. The effect of large-scale testing has been fully verified in the international community. We developed a practical dynamic infectious disease model-SETPG (A + I) RD + APT by considering the effects of the all-people test (APT). The model is useful for studying effects of screening measures and providing a more realistic modelling with all-people-test strategies, which require everybody in a population to be tested for infection. In prior work, a total of 370 epidemic cases were collected. We collected three kinds of known cases: the cumulative number of daily incidences, daily cumulative recovery, and daily cumulative deaths in Hong Kong and the United States between 22 January 2020 and 13 November 2020 were simulated. In two essential strategies of the integrated SETPG (A + I) RD + APT model, comparing the cumulative number of screenings in derivative experiments based on daily detection capability and tracking system application rate, we evaluated the performance of the timespan required for the basic regeneration number (R0) and real-time regeneration number (R0t) to reach 1; the optimal policy of each experiment is available, and the screening effect is evaluated by screening performance indicators. with the binary encoding screening method, the number of screenings for the target population is 8667 in HK and 1,803,400 in the U.S., including 6067 asymptomatic cases in HK and 1,262,380 in the U.S. as well as 2599 cases of mild symptoms in HK and 541,020 in the U.S.; there were also 8.25 days of screening timespan in HK and 9.25 days of screening timespan required in the U.S. and a daily detectability of 625,000 cases in HK and 6,050,000 cases in the U.S. Using precise tracking technology, number of screenings for the target population is 6060 cases in HK and 1,766,420 cases in the U.S., including 4242 asymptomatic cases in HK and 1,236,494 cases in the U.S. as well as 1818 cases of mild symptoms in HK and 529,926 cases in the U.S. Total screening timespan (TS) is 8.25~9.25 days. According to the proposed infectious dynamics model that adapts to the all-people test, all of the epidemic cases were reported for fitting, and the result seemed more reasonable, and epidemic prediction became more accurate. It adapted to densely populated metropolises for APT on prevention.
This paper proposes a framework to learn about irregular and abnormal behavior of access card user's pattern based on the real-time analysis data. The aim of the technique is to overcome the security level problem set by human and therefore relying on the collected real-time data in order to study the pattern of the access users. The concept of studying the irregular bahavior of the access user is using Predicate Logics for rule checking. An architecture of the model is described which includes the relationship between the user-level and the dependants as well as the accessing points.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.